CD151 and osteosarcoma: Collectively, these data demonstrated the in vivo efficacy of myriocin in inhibiting osteosarcoma growth and indicated that CD151 expression was a potentially useful biomarker for predicting the efficacy of sphingolipid metabolism inhibition.